Current Opinion in Pharmacology, Vol
For instance, Lixisenatide was evaluated for safety, efficacy, and adverse events in a randomized, double-blind, placebo-controlled, parallel-group, 13-week study of 542 patients with Type 2 diabetes inadequately controlled on metformin (1000 mg/day) treated with subcutaneous lixisenatide doses of 5, 10, 20, or 30 g once daily or twice daily or placebo
BPC-157 is a powerful regenerative peptide that can assist in healing a variety of injuries
Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States
Remember, each individuals journey is unique, and with determination, support, and the power of GLP-1, success in weight management becomes an attainable reality for anyone willing to embark on this transformative road to well-being
What doses of Retatrutide are being studied